| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of likert and visual analogue scales for measuring change in function
|
|
|
1987
|
8 |
3 |
p. 294-
1 p.
|
artikel
|
| 2 |
A design for combining screening trials and tests for treatment efficacy
|
|
|
1987
|
8 |
3 |
p. 295-
1 p.
|
artikel
|
| 3 |
A method for predicting accrual, cost, and paper flow in clinical trials
|
Piantadosi, Steven
|
|
1987
|
8 |
3 |
p. 202-215
14 p.
|
artikel
|
| 4 |
A microcomputer-based distributed data management system for a large cooperative study of transfusion-associated AIDS
|
|
|
1987
|
8 |
3 |
p. 308-
1 p.
|
artikel
|
| 5 |
A multicenter trial of endarterectomy for asymptomatic carotid atherosclerosis
|
|
|
1987
|
8 |
3 |
p. 285-
1 p.
|
artikel
|
| 6 |
A multicenter trip-reporting system
|
|
|
1987
|
8 |
3 |
p. 302-
1 p.
|
artikel
|
| 7 |
Analysis of data from the VA cooperative study on antiplatelet therapy after coronary artery bypass surgery
|
|
|
1987
|
8 |
3 |
p. 298-
1 p.
|
artikel
|
| 8 |
Analysis of squared tables of ordinal data with applications to clinical trials
|
|
|
1987
|
8 |
3 |
p. 283-
1 p.
|
artikel
|
| 9 |
Analyzing survival from initial diagnosis
|
|
|
1987
|
8 |
3 |
p. 283-
1 p.
|
artikel
|
| 10 |
Analyzing toxicity in chemotherapy clinical trials
|
|
|
1987
|
8 |
3 |
p. 290-
1 p.
|
artikel
|
| 11 |
An international survey to identify unpublished and ongoing perinatal trials
|
|
|
1987
|
8 |
3 |
p. 287-
1 p.
|
artikel
|
| 12 |
A posteriori evaluation of the hypotheses made when designing randomized clinical trials: A study from five trials of the GETCB
|
|
|
1987
|
8 |
3 |
p. 302-
1 p.
|
artikel
|
| 13 |
Assessing the magnitude of publication bias in clinical trials
|
|
|
1987
|
8 |
3 |
p. 311-312
2 p.
|
artikel
|
| 14 |
Assessment instrument for an interferon trial of recurrent respiratory papillomatosis
|
|
|
1987
|
8 |
3 |
p. 307-308
2 p.
|
artikel
|
| 15 |
Assessment of quality of life in congestive heart failure patients
|
|
|
1987
|
8 |
3 |
p. 294-295
2 p.
|
artikel
|
| 16 |
Assessment of the impact of coding variability on the analysis of data from 24-hour food records
|
|
|
1987
|
8 |
3 |
p. 288-289
2 p.
|
artikel
|
| 17 |
Assessment of the quality of blood pressure determinations in the hypertension prevention trial (HPT)
|
|
|
1987
|
8 |
3 |
p. 287-
1 p.
|
artikel
|
| 18 |
A two-stage design for choosing among several experimental treatments in phase III clinical trials
|
|
|
1987
|
8 |
3 |
p. 295-
1 p.
|
artikel
|
| 19 |
Automated trial management in a multicenter cancer control study
|
|
|
1987
|
8 |
3 |
p. 301-
1 p.
|
artikel
|
| 20 |
Back to the future, a data management system that tracks data entry and can recover past databases with current corrections
|
|
|
1987
|
8 |
3 |
p. 310-
1 p.
|
artikel
|
| 21 |
Baseline covariate intrablock correlations
|
|
|
1987
|
8 |
3 |
p. 283-
1 p.
|
artikel
|
| 22 |
Biochemical markers of compliance in the physicians' health study
|
|
|
1987
|
8 |
3 |
p. 289-
1 p.
|
artikel
|
| 23 |
Centralized manual evaluations of serial coronary arteriograms
|
|
|
1987
|
8 |
3 |
p. 281-
1 p.
|
artikel
|
| 24 |
Challenges in designing and conducting clinical trials of rare conditions
|
|
|
1987
|
8 |
3 |
p. 311-
1 p.
|
artikel
|
| 25 |
Changing eligibility criteria during patient recruitment: What does it buy and what is the cost?
|
|
|
1987
|
8 |
3 |
p. 296-
1 p.
|
artikel
|
| 26 |
Classification of reports of patient hospitalization and death: The ETDRS electronic tracking system
|
|
|
1987
|
8 |
3 |
p. 309-
1 p.
|
artikel
|
| 27 |
Clinical dictionary management system
|
|
|
1987
|
8 |
3 |
p. 309-310
2 p.
|
artikel
|
| 28 |
Comparison of changes in the presence of informative right censoring
|
|
|
1987
|
8 |
3 |
p. 299-
1 p.
|
artikel
|
| 29 |
Comparison of dietary component correlations resulting from nutritional epidemiology vs a prospective clinical intervention
|
|
|
1987
|
8 |
3 |
p. 304-305
2 p.
|
artikel
|
| 30 |
Comparison of quality of life instruments in a setting of a clinical trial
|
|
|
1987
|
8 |
3 |
p. 293-294
2 p.
|
artikel
|
| 31 |
Comparison of statistical methods for combining event rates from clinical trials
|
|
|
1987
|
8 |
3 |
p. 286-
1 p.
|
artikel
|
| 32 |
Conducting crossover trials when patients are unstable: An approach, and an example
|
|
|
1987
|
8 |
3 |
p. 298-
1 p.
|
artikel
|
| 33 |
Considerations in the design of a large-scale clinical trial of short-course preventive therapy for tuberculosis
|
|
|
1987
|
8 |
3 |
p. 298-299
2 p.
|
artikel
|
| 34 |
Coordinating center follow-up in the veterans administration cooperative study of coronary artery bypass surgery
|
Peduzzi, Peter
|
|
1987
|
8 |
3 |
p. 190-201
12 p.
|
artikel
|
| 35 |
Cost-effectiveness in a VA cooperative study of prostate surgery for benign prostatic hyperplasia in elderly men
|
|
|
1987
|
8 |
3 |
p. 292-293
2 p.
|
artikel
|
| 36 |
Cost minimization in clinical trials
|
|
|
1987
|
8 |
3 |
p. 297-
1 p.
|
artikel
|
| 37 |
Definition of a surrogate endpoint
|
|
|
1987
|
8 |
3 |
p. 304-
1 p.
|
artikel
|
| 38 |
Design and analysis of a trial where experimental units are nested within patients
|
|
|
1987
|
8 |
3 |
p. 296-
1 p.
|
artikel
|
| 39 |
Design and implementation of six trials in a new modality for cancer treatment
|
|
|
1987
|
8 |
3 |
p. 288-
1 p.
|
artikel
|
| 40 |
Design features of a controlled clinical trial to assess the effect of a calcium entry blocker upon the progression of coronary artery disease
|
Waters, David
|
|
1987
|
8 |
3 |
p. 216-242
27 p.
|
artikel
|
| 41 |
Design for phase II testing of new agents within a phase III trial with crossover
|
|
|
1987
|
8 |
3 |
p. 296-297
2 p.
|
artikel
|
| 42 |
Designing clinical trials with arbitrary specification of survival functions and for the log rank or generalized Wilcoxon test
|
Halpern, Jerry
|
|
1987
|
8 |
3 |
p. 177-189
13 p.
|
artikel
|
| 43 |
Design of group sequential clinical trials with survival endpoints
|
|
|
1987
|
8 |
3 |
p. 311-
1 p.
|
artikel
|
| 44 |
Developing informed consent documents for multi-institutional cooperative groups
|
|
|
1987
|
8 |
3 |
p. 301-
1 p.
|
artikel
|
| 45 |
Disaster prevention and recovery in the management of clinical trials data
|
|
|
1987
|
8 |
3 |
p. 307-
1 p.
|
artikel
|
| 46 |
Distributed data analysis in collaborative studies: The cardia strategy
|
|
|
1987
|
8 |
3 |
p. 281-282
2 p.
|
artikel
|
| 47 |
Distributed system for treatment assignment and limited data entry
|
|
|
1987
|
8 |
3 |
p. 308-
1 p.
|
artikel
|
| 48 |
Early termination of a phase II trial
|
|
|
1987
|
8 |
3 |
p. 306-
1 p.
|
artikel
|
| 49 |
Effects of prerandomization exclusion on generalizability
|
|
|
1987
|
8 |
3 |
p. 289-
1 p.
|
artikel
|
| 50 |
Eighth annual meeting society for clinical trials
|
|
|
1987
|
8 |
3 |
p. 267-279
13 p.
|
artikel
|
| 51 |
Electronic drug accountability
|
|
|
1987
|
8 |
3 |
p. 303-
1 p.
|
artikel
|
| 52 |
Empirical bayes estimation of subgroup effects in clinical trials
|
|
|
1987
|
8 |
3 |
p. 283-
1 p.
|
artikel
|
| 53 |
Enumeration of the optimal designs for a grouped sequential trial with binomial outcome
|
|
|
1987
|
8 |
3 |
p. 297-
1 p.
|
artikel
|
| 54 |
Estimates of absolute risk of recurrence in clinical trials for cancer
|
|
|
1987
|
8 |
3 |
p. 281-
1 p.
|
artikel
|
| 55 |
Evaluating serial coronary arteriograms: Progress report on the POSCH AI project
|
|
|
1987
|
8 |
3 |
p. 291-
1 p.
|
artikel
|
| 56 |
Graphical aids in the analysis of demographic data and drug-demographic variable interaction
|
|
|
1987
|
8 |
3 |
p. 307-
1 p.
|
artikel
|
| 57 |
Incorporating patient preferences when interpreting clinical trials: Is adjuvant chemotherapy for breast cancer worth it?
|
|
|
1987
|
8 |
3 |
p. 294-
1 p.
|
artikel
|
| 58 |
Integration of a cost-effectiveness component into the VA cooperative study 246: prostatic surgery for moderately symptomatic benign prostatic hyperplasia in elderly men
|
|
|
1987
|
8 |
3 |
p. 305-
1 p.
|
artikel
|
| 59 |
Interpreting physician participation in randomized clinical trials: The physician orientation profile
|
|
|
1987
|
8 |
3 |
p. 284-
1 p.
|
artikel
|
| 60 |
Laboratory quality control in a study with local and central laboratories
|
|
|
1987
|
8 |
3 |
p. 303-
1 p.
|
artikel
|
| 61 |
Liver enzyme elevations in clinical trials involving diabetic patients
|
|
|
1987
|
8 |
3 |
p. 301-
1 p.
|
artikel
|
| 62 |
Maintaining a distributed data system
|
|
|
1987
|
8 |
3 |
p. 309-
1 p.
|
artikel
|
| 63 |
Management of a large clinical dataset from a long-term study for quality assurance review
|
|
|
1987
|
8 |
3 |
p. 307-
1 p.
|
artikel
|
| 64 |
Methodologic and practical considerations in conducting a clinical trial in brain resuscitation
|
|
|
1987
|
8 |
3 |
p. 285-
1 p.
|
artikel
|
| 65 |
Monitoring for unbiased treatment allocation in a VA cooperative study when randomization is done locally
|
|
|
1987
|
8 |
3 |
p. 292-
1 p.
|
artikel
|
| 66 |
Ninth annual meeting of the society for clinical trials
|
|
|
1987
|
8 |
3 |
p. 313-314
2 p.
|
artikel
|
| 67 |
Nonrespondents in a post-myocardial infarction trial
|
|
|
1987
|
8 |
3 |
p. 289-
1 p.
|
artikel
|
| 68 |
Obtaining quality-of-life and cost-effectiveness data by the use of lay outcome assessors: A report from a multicenter clinical trial
|
|
|
1987
|
8 |
3 |
p. 295-
1 p.
|
artikel
|
| 69 |
Optimal restricted two-stage designs
|
|
|
1987
|
8 |
3 |
p. 297-
1 p.
|
artikel
|
| 70 |
Order-restricted inference methods with applications to dose-response designs
|
|
|
1987
|
8 |
3 |
p. 291-
1 p.
|
artikel
|
| 71 |
Outcome assessment can be improved by using measures of longitudinal association between treatment and health
|
|
|
1987
|
8 |
3 |
p. 303-304
2 p.
|
artikel
|
| 72 |
Patient information booklets as part of the informed consent process
|
|
|
1987
|
8 |
3 |
p. 300-
1 p.
|
artikel
|
| 73 |
Permuted blocks in RCTs
|
|
|
1987
|
8 |
3 |
p. 298-
1 p.
|
artikel
|
| 74 |
Perusing the literature
|
Hawkins, Barbara S.
|
|
1987
|
8 |
3 |
p. 255-265
11 p.
|
artikel
|
| 75 |
Physician awareness and assessment of the result of a RCT
|
|
|
1987
|
8 |
3 |
p. 293-
1 p.
|
artikel
|
| 76 |
Posttraumatic epilepsy prevention: A clinical trial
|
|
|
1987
|
8 |
3 |
p. 310-311
2 p.
|
artikel
|
| 77 |
Power dilution due to provider nonadherence
|
|
|
1987
|
8 |
3 |
p. 290-
1 p.
|
artikel
|
| 78 |
Prediction of final results from partial results
|
|
|
1987
|
8 |
3 |
p. 280-
1 p.
|
artikel
|
| 79 |
Problems in design, execution, and analysis of cancer clinical trials (CCTs) determined during FDA review
|
|
|
1987
|
8 |
3 |
p. 286-
1 p.
|
artikel
|
| 80 |
Quality control measures prior to initiation of a multicenter clinical trial
|
|
|
1987
|
8 |
3 |
p. 300-301
2 p.
|
artikel
|
| 81 |
Quality control of adverse reaction reports in a long-term multicenter clinical trial
|
|
|
1987
|
8 |
3 |
p. 302-303
2 p.
|
artikel
|
| 82 |
Reasons for non-drug-related loss to a multicenter epilepsy study
|
|
|
1987
|
8 |
3 |
p. 306-
1 p.
|
artikel
|
| 83 |
Recruitment in NHLBI population-based studies and randomized clinical trials: Data analysis and survey results
|
|
|
1987
|
8 |
3 |
p. 287-
1 p.
|
artikel
|
| 84 |
Sample size determination for comparison of rates of change with lognormal distributions
|
|
|
1987
|
8 |
3 |
p. 299-
1 p.
|
artikel
|
| 85 |
Side effects analysis in european organization for research and treatment of cancer (EORTC) phase II cancer clinical trials
|
|
|
1987
|
8 |
3 |
p. 282-
1 p.
|
artikel
|
| 86 |
Society for clinical trials officers, board of directors, program committee, and secretariat
|
|
|
1987
|
8 |
3 |
p. 266-
1 p.
|
artikel
|
| 87 |
Sources of heterogeneity in secondary trials for prevention of mortality following myocardial infarction
|
|
|
1987
|
8 |
3 |
p. 304-
1 p.
|
artikel
|
| 88 |
Specialized research pharmacy coordinating center for clinical trials involving drugs and devices
|
|
|
1987
|
8 |
3 |
p. 299-300
2 p.
|
artikel
|
| 89 |
Successful blinding in cardiac arrhythmia pilot study (CAPS)
|
|
|
1987
|
8 |
3 |
p. 288-
1 p.
|
artikel
|
| 90 |
Survival analysis techniques in angina pectoris trials
|
|
|
1987
|
8 |
3 |
p. 291-
1 p.
|
artikel
|
| 91 |
Technical quality assessment of randomized control trials (RCTs)
|
|
|
1987
|
8 |
3 |
p. 282-
1 p.
|
artikel
|
| 92 |
Telephone as a method to evaluate adherence to therapy
|
|
|
1987
|
8 |
3 |
p. 306-
1 p.
|
artikel
|
| 93 |
Telephone survey as an adjunct to evaluating clinical trials: The hypertension and prevention trial (HPT)
|
|
|
1987
|
8 |
3 |
p. 284-
1 p.
|
artikel
|
| 94 |
Termination of a clinical trial with no treatment group difference: The lupus nephritis collaborative study
|
|
|
1987
|
8 |
3 |
p. 280-
1 p.
|
artikel
|
| 95 |
The community trial in developing countries: A mechanism for international public health research
|
|
|
1987
|
8 |
3 |
p. 292-
1 p.
|
artikel
|
| 96 |
The design of a randomized, multicenter study of sodium dichloroacetate (DCA) as a treatment for lactic acidosis
|
|
|
1987
|
8 |
3 |
p. 291-292
2 p.
|
artikel
|
| 97 |
The effect of unscheduled crossovers on the power of a clinical trial
|
|
|
1987
|
8 |
3 |
p. 296-
1 p.
|
artikel
|
| 98 |
The multicenter recruitment and single-center conducting model in cardiovascular research
|
|
|
1987
|
8 |
3 |
p. 305-306
2 p.
|
artikel
|
| 99 |
Theory of evidence and clinical trials
|
|
|
1987
|
8 |
3 |
p. 312-
1 p.
|
artikel
|
| 100 |
The prophylactic clinical trial as an epidemiologic resource
|
Leviton, Alan
|
|
1987
|
8 |
3 |
p. 243-254
12 p.
|
artikel
|
| 101 |
The silicone study—a randomized clinical trial
|
|
|
1987
|
8 |
3 |
p. 303-
1 p.
|
artikel
|
| 102 |
The usefulness of a working group for institutional data managers
|
|
|
1987
|
8 |
3 |
p. 310-
1 p.
|
artikel
|
| 103 |
The use of a distributed data entry system in a multicenter study
|
|
|
1987
|
8 |
3 |
p. 308-
1 p.
|
artikel
|
| 104 |
The U.S.-Finland lung cancer prevention trial: A report on study design and recruitment
|
|
|
1987
|
8 |
3 |
p. 286-
1 p.
|
artikel
|
| 105 |
To perfuse or not to perfuse?
|
|
|
1987
|
8 |
3 |
p. 281-
1 p.
|
artikel
|
| 106 |
Trial of antihypertensive interventions and management: Design features
|
|
|
1987
|
8 |
3 |
p. 285-286
2 p.
|
artikel
|
| 107 |
Use of data transmission networks in clinical trials: Benefits and limits
|
|
|
1987
|
8 |
3 |
p. 284-
1 p.
|
artikel
|
| 108 |
Use of Epstein-Barr antibody studies in etiologic differentiation of aminotransferase elevations during clinical trials
|
|
|
1987
|
8 |
3 |
p. 305-
1 p.
|
artikel
|
| 109 |
Use of the yearly event-specific conditional probability in the analysis of two randomized clinical trials in lung cancer: Different patterns of locoregional and metastatic relapses
|
|
|
1987
|
8 |
3 |
p. 290-
1 p.
|
artikel
|
Tijdschrift beschrijving